Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
Submitted by
admin
on May 22, 2017 - 12:47pm
Source:
RAPS.org
News Tags:
Roche
Actemra
FDA
giant cell arteritis
tocilizumab
Headline:
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
Do Not Allow Advertisers to Use My Personal information
